Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas.
de Sousa GR, Salomão KB, Nagano LFP, Riemondy KA, Chagas PS, Veronez LC, Saggioro FP, Marie SKN, Yunes JA, Cardinalli IA, Brandalise SR, de Paula Queiroz RG, Scrideli CA, Donson AM, Foreman NK, Tone LG, Valera ET.
de Sousa GR, et al. Among authors: valera et.
Cancer Gene Ther. 2023 Aug;30(8):1105-1113. doi: 10.1038/s41417-023-00616-z. Epub 2023 Apr 11.
Cancer Gene Ther. 2023.
PMID: 37041276